Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Professor Richard Edmondson

Newcastle AuthorsTitleYearFull text
Dr Aiste McCormick
Dr Peter Donoghue
Michelle Dixon
Dr Rachel O'Donnell
James Murray
et al.		Ovarian Cancers Harbour Defects in Non-Homologous End Joining Resulting in Resistance to Rucaparib2017
Fiona Middleton
Dr Miranda Morton
Dr Claire Elstob
Dr Sarah Fordham
Dr Ashleigh Herriott
et al.		Common cancer-associated imbalances in the DNA damage response confer sensitivity to single agent ATR inhibition2015
Dr Aiste McCormick
Dr Peter Donoghue
Michelle Dixon
Dr Rachel O'Donnell
Dr Angelika Kaufmann
et al.		Defects in non-homologous end joining pathway in ovarian cancers results in resistance to rucaparib2015
Dr Rachel O'Donnell
Dr Angelika Kaufmann
Dr Aiste McCormick
Professor Nicola Curtin
Professor Richard Edmondson
Intra- and inter-tumour heterogeneity in epithelial ovarian cancer: consequences for biomarker dependent stratification of therapies2015
Dr Aiste McCormick
Dr Rachel O'Donnell
Dr Angelika Kaufmann
Professor Richard Edmondson
Phosphatase and tensin homolog (PTEN) is a potential target for ovarian cancer sensitisation to cytotoxic agents2015
Dr Aiste McCormick
Michelle Dixon
Dr Rachel O'Donnell
Dr Angelika Kaufmann
Professor Richard Edmondson
PTEN function is important in determining ovarian cancer sensitivity to cytotoxic agents2015
Dr Miranda Morton
Dr Ian Forrest
Becci Sharrock
Maria Lane
Dr Angelika Kaufmann
et al.		Assessing the function of homologous recombination DNA repair in malignant pleural effusion (MPE) samples2014
Laura Woodhouse
Dr Aiste McCormick
Dr Rachel O'Donnell
Dr Angelika Kaufmann
Professor Richard Edmondson
Development of a Functional Assay to Determine the Nucleotide Excision Repair Status of Epithelial Overian Cancer2014
Dr Asima Mukhopadhyay
Michelle Dixon
Dr Evan Mulligan
James Murray
Professor Nicola Curtin
et al.		Evaluation of different methods to assess homologous recombination status and sensitivity to parp inhibitors in ovarian cancer2014
Dr Scott Wilkes
Professor Richard Edmondson
What do we do with all the false-positive CA125s?2013
Dr Ahmed Elattar
Dr Asima Mukhopadhyay
Dr Fadhel Shaheen
Professor Ruth Plummer
Professor Craig Robson
et al.		Androgen receptor expression is a biological marker for androgen sensitivity in high grade serous epithelial ovarian cancer2012
Dr Asima Mukhopadhyay
Professor Ruth Plummer
Dr Ahmed Elattar
Dr San Soo Hoo
Bisha Uzir
et al.		Clinicopathological features of homologous recombination deficient epithelial ovarian cancers: Sensitivity to PARP inhibitors, platinum and survival2012
Dr Asima Mukhopadhyay
Professor Ruth Plummer
Dr Ahmed Elattar
Dr San Soo Hoo
Bisha Uzir
et al.		Clinicopathological features of homologous recombination deficient epithelial ovarian cancers: Sensitivity to PARP inhibitors, platinum and survival2012
Dr Asima Mukhopadhyay
Professor Ruth Plummer
Dr Ahmed Elattar
Dr San Soo Hoo
Bisha Uzir
et al.		Clinicopathological Features of Homologous Recombination-Deficient Epithelial Ovarian Cancers: Sensitivity to PARP Inhibitors, Platinum, and Survival2012
Dr Aiste McCormick
Dr Asima Mukhopadhyay
Professor Ruth Plummer
Professor Nicola Curtin
Professor Richard Edmondson
Defective homologous recombination in human cancers2012
1234